Literature DB >> 3567061

Liver tumour blood flow and responses to arterial embolization measured by dynamic hepatic scintigraphy.

A D Flowerdew, M I McLaren, J S Fleming, A J Britten, D M Ackery, S J Birch, I Taylor, S J Karran.   

Abstract

Liver and tumour blood flow has been studied in 30 patients with multiple liver metastases and in 14 patients with solitary liver tumours by means of dynamic hepatic scintigraphy. Observations were compared with those of a group of 33 control subjects. Haemodynamic changes were also measured in 10 patients who underwent hepatic arterial embolization (HAE). The mesenteric fraction (MF) to tumour regions in 32 subjects showed a wide range compared with control subjects. In 9 patients the MF to the tumour region was within the normal range suggesting that some tumours may possess a portal venous supply. The MF to the uninvolved liver regions was below the normal range in 25% of patients, indicating that HAE could be hazardous in this group. Following HAE the MF rose in all 4 tumour regions and fell in 4 non-embolized uninvolved liver regions. No increase in colloid clearance rate (k) was seen though a significant decrease occurred in 4 patients. These changes may well represent increased portal venous flow into tumours.

Entities:  

Mesh:

Year:  1987        PMID: 3567061      PMCID: PMC2001741          DOI: 10.1038/bjc.1987.52

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  12 in total

1.  Ligation of hepatic and splenic arteries in treatment of cirrhosis with ascites.

Authors:  W F RIENHOFF; A C WOODS
Journal:  J Am Med Assoc       Date:  1953-06-20

2.  Angiographic study of the collateral circulation to the liver after ligation of the hepatic artery in man.

Authors:  S Bengmark; K Rosengren
Journal:  Am J Surg       Date:  1970-06       Impact factor: 2.565

3.  Dynamic liver scanning in cirrhosis.

Authors:  M I McLaren; J S Fleming; B H Walmsley; D M Ackery; I Taylor; S J Karran
Journal:  Br J Surg       Date:  1985-05       Impact factor: 6.939

Review 4.  Liver blood flow. I. Intrinsic and nervous control of liver blood flow.

Authors:  P D Richardson; P G Withrington
Journal:  Gastroenterology       Date:  1981-07       Impact factor: 22.682

5.  In vivo assessment of hepatic-arterial and portal-venous components of liver perfusion: concise communication.

Authors:  J S Fleming; N L Humphries; S J Karran; B A Goddard; D M Ackery
Journal:  J Nucl Med       Date:  1981-01       Impact factor: 10.057

6.  Transcatheter arterial embolization for hepatocellular carcinoma. Benefits and limitations for unresectable cases with liver cirrhosis evaluated by comparison with other conservative treatments.

Authors:  Y Sato; K Fujiwara; I Ogata; Y Ohta; S Hayashi; Y Oka; S Furui; H Oka
Journal:  Cancer       Date:  1985-06-15       Impact factor: 6.860

7.  Hepatic artery embolization in the treatment of hepatic neoplasms.

Authors:  V P Chuang; S Wallace
Journal:  Radiology       Date:  1981-07       Impact factor: 11.105

8.  Deranged liver blood flow patterns in the detection of liver metastases.

Authors:  S H Leveson; P A Wiggins; G R Giles; A Parkin; P J Robinson
Journal:  Br J Surg       Date:  1985-02       Impact factor: 6.939

9.  Therapeutic Ivalon embolization of hepatic tumors.

Authors:  V P Chuang; S Wallace; C S Soo; C Charnsangavej; T Bowers
Journal:  AJR Am J Roentgenol       Date:  1982-02       Impact factor: 3.959

10.  Postmortem examination of the blood supply and vascular pattern of small liver metastases in man.

Authors:  G Lin; A Lunderquist; I Hägerstrand; E Boijsen
Journal:  Surgery       Date:  1984-09       Impact factor: 3.982

View more
  2 in total

Review 1.  SIRT of liver metastases: physiological and pathophysiological considerations.

Authors:  Christophe Van de Wiele; Alex Maes; Eddy Brugman; Yves D'Asseler; Bart De Spiegeleer; Gilles Mees; Karin Stellamans
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-07-17       Impact factor: 9.236

2.  An association between parameters of liver blood flow and percentage hepatic replacement with tumour.

Authors:  T M Hunt; A D Flowerdew; A J Britten; J S Fleming; S J Karran; I Taylor
Journal:  Br J Cancer       Date:  1989-03       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.